Skip to main content
Equibles

Avoro Capital Advisors LLC

Position in QURE — uniQure N.V.

CIK 1633313 NEW YORK, NY
Back to QURE Full portfolio

Position in QURE

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$309,881,408
+$212,442,030 QoQ
Shares Held
6,727,777
+12.9% QoQ
Ownership
10.7%
of shares outstanding
% of Portfolio
2.78%
of 13F equity value
Holder Rank
#1
of 255 holders
Holding Since
Mar 2020
10 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in QURE Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Avoro Capital Advisors LLC holds $9,631,167,263 across 25 Biotechnology names. QURE ranks #13 (3.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ASND
Ascendis Pharma A/S
 5,111,111 $1,363,235,525
2 KRYS
Krystal Biotech, Inc.
 2,888,888 $1,073,713,002
3 MDGL
Madrigal Pharmaceuticals, Inc.
 1,833,333 $984,408,154
4 ARGX
Argenx SE
 1,000,000 $927,770,000
5 ARWR
Arrowhead Pharmaceuticals, Inc.
 11,355,555 $925,591,288
6 KYMR
Kymera Therapeutics, Inc.
 7,474,747 $857,129,238
7 RVMD
Revolution Medicines, Inc.
 2,297,000 $430,182,160
8 CYTK
Cytokinetics Inc
 4,999,999 $425,949,914

All Filings in QURE

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $309,881,408 6,727,777
2026-03-31 $97,439,378 5,959,595
2025-12-31 $147,169,500 6,150,000
2025-09-30 $259,422,196 4,444,444
2025-06-30 $50,532,500 3,625,000
2025-03-31 $23,055,000 2,175,000
2024-12-31 $38,410,500 2,175,000
2020-09-30 $64,452,500 1,750,000
2020-06-30 $67,590,000 1,500,000
2020-03-31 $78,292,500 1,650,000